These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8093963)

  • 1. Clearance of HIV-1 viraemia after seroconversion.
    Clementi M; Bagnarelli P; Menzo S; Valenza A; Manzin A; Varaldo PE
    Lancet; 1993 Jan; 341(8840):315-6. PubMed ID: 8093963
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV viraemia and seroconversion.
    Lu W; Eme D; Andrieu JM
    Lancet; 1993 Jan; 341(8837):113. PubMed ID: 8093378
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma viraemia in seronegative HIV-1 infected individuals.
    Dis Markers; 1991; 9(6):351-2. PubMed ID: 1823326
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
    Dis Markers; 1990; 8(3):159-61. PubMed ID: 2125536
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma viraemia in seronegative HIV-1-infected individuals.
    Ensoli F; Fiorelli V; Mezzaroma I; D'Offizi G; Rainaldi L; Luzi G; Fiorilli M; Aiuti F
    AIDS; 1991 Oct; 5(10):1195-9. PubMed ID: 1786147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?
    Ariyoshi K; Harwood E; Chiengsong-Popov R; Weber J
    Lancet; 1992 Nov; 340(8830):1257-8. PubMed ID: 1359323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV1 quantitation in infected patients: a comparison of cell viraemia, plasma viraemia and R-HEV.
    Masquelier B; Faivre R; Paty MC; Fleury HJ
    Res Virol; 1992; 143(1):17-22. PubMed ID: 1348865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical loci of HIV-associated immune activation and association with viraemia.
    Iyengar S; Chin B; Margolick JB; Sabundayo BP; Schwartz DH
    Lancet; 2003 Sep; 362(9388):945-50. PubMed ID: 14511927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction.
    Aoki-Sei S; Yarchoan R; Kageyama S; Hoekzema DT; Pluda JM; Wyvill KM; Broder S; Mitsuya H
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1263-70. PubMed ID: 1520538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure.
    Busch MP; Satten GA
    Am J Med; 1997 May; 102(5B):117-24; discussion 125-6. PubMed ID: 9845513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy.
    Ved Brat SS; Shepherd LP; Boulberhane A; Pierce PF; Hellman KB
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1271-81. PubMed ID: 1520539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decay of HIV-1 infectivity in whole blood, plasma and peripheral blood mononuclear cells.
    Cao Y; Ngai H; Gu G; Ho DD
    AIDS; 1993 Apr; 7(4):596-7. PubMed ID: 8507427
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres.
    Tamalet C; Masquelier B; Ferchal F; Agut H; Puel J; Brun-Vézinet F; Fleury H; Rouzioux C
    AIDS; 1992 Nov; 6(11):1403-4. PubMed ID: 1361750
    [No Abstract]   [Full Text] [Related]  

  • 14. Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia.
    Rothen M; Gratzl S; Hirsch HH; Moroni C
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):771-9. PubMed ID: 9171221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary HIV type 1 infection.
    Kassutto S; Rosenberg ES
    Clin Infect Dis; 2004 May; 38(10):1447-53. PubMed ID: 15156484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection.
    Mackewicz CE; Yang LC; Lifson JD; Levy JA
    Lancet; 1994 Dec; 344(8938):1671-3. PubMed ID: 7996961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and nanobacteria.
    Pretorius AM; Sommer AP; Aho KM; Kajander EO
    HIV Med; 2004 Nov; 5(6):391-3. PubMed ID: 15544689
    [No Abstract]   [Full Text] [Related]  

  • 18. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.
    Saag MS; Crain MJ; Decker WD; Campbell-Hill S; Robinson S; Brown WE; Leuther M; Whitley RJ; Hahn BH; Shaw GM
    J Infect Dis; 1991 Jul; 164(1):72-80. PubMed ID: 1676046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.
    Daar ES; Moudgil T; Meyer RD; Ho DD
    N Engl J Med; 1991 Apr; 324(14):961-4. PubMed ID: 1823118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious immune complexes in HIV-1-infected patients.
    Fiscus SA; Folds JD; van der Horst CM
    Viral Immunol; 1993; 6(2):135-41. PubMed ID: 8216713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.